B

Barinthus Biotherapeutics plc
D

BRNS

0.86080
USD
-0.10
(-10.33%)
مغلق
حجم التداول
50
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
34,724,151
أصول ذات صلة
A
ADNT
-0.045
(-0.24%)
18.895 USD
A
ALV
0.300
(0.27%)
110.330 USD
APTV
APTV
0.070
(0.10%)
67.640 USD
B
BWA
0.470
(1.43%)
33.300 USD
F
F
0.000
(0.00%)
10.425 USD
GM
GM
-0.190
(-0.39%)
48.090 USD
HMC
HMC
0.305
(1.04%)
29.670 USD
L
LEA
0.640
(0.71%)
91.290 USD
L
LKQ
-0.300
(-0.81%)
36.850 USD
TSLA
TSLA
5.92
(1.87%)
322.14 USD
T
TEN
0.740
(3.61%)
21.240 USD
المزيد
المقالات

العنوان: Barinthus Biotherapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.